FOR THE PAST SEVERAL YEARS, and particularly since Congress passed the Patient Access to Medicare Act in 2014, clinical labs have focused on controlling costs, as they should. After all, PAMA calls for steep cuts in what the federal Centers for Medicare and Medicaid Services will pay clinical labs beginning Jan. 1, 2018. (See TDRs,
Tag: quality improvement
CEO SUMMARY: In the latest chapter of an explosive case at the University of Kansas Medical Center that includes claims of a cancer misdiagnosis, an unnecessary surgery, and a cover-up that involves the former chair of pathology, the patient has sued for fraud, negligence, and civil conspiracy. After a whistle-blowing pathologist filed an earlier lawsuit,
INNOVATIVE CLINICAL LABS are making significant changes to accommodate the shift from volume to values. In one change, they are collaborating with clinicians to use lab test data to improve patient outcomes.
In another, they are collecting the clinical data from these efforts to publish the outcomes in peer-reviewed medical journals to spread the word about
CEO SUMMARY: Being accredited to this internationally recognized standard for quality and competence communicates to clients and prospective clients that one of the nation’s largest clinical labs is committed to the highest standards of quality. Clients already knew about that commitment but now have definitive proof, ARUP said. Also, lab administrators believed that gaining accreditation
CEO SUMMARY: Genetic tests that lack two essentials are troublesome for the nation’s health insurers. Those essentials are clinical validity and clinical utility. During a recent webinar, two executives from major health insurers stressed the need for genetic testing labs to provide acceptable evidence that their genetic test is accurate and that it produces information
CEO SUMMARY: At the University of Michigan Medical Center, the Department of Pathology is learning new ways to add value that include face-to-face meetings with patients as part of UMMC’s patient- and family-centered care initiative. One lesson learned is that patients appreciate the opportunity to get a better understanding of the results from both anatomic
CEO SUMMARY: Two years ago, the rate of hemolysis in blood drawn in the Cleveland Clinic’s Emergency Department was about nine times higher than the ASCP recommended rate of 2%. With a two-year cooperative agreement and funding from the federal Centers for Disease Control and Prevention, the ED and clinical lab staff developed a quality
CEO SUMMARY: By now, most pathologists and clinical laboratory administrators recognize that effective use of information technology will be a critical success factor as healthcare systems transform to do population health management and to use “big data” with value-based payment models. As the provider of laboratory information systems to hundreds of the nation’s major hospitals,
CEO SUMMARY: When Intermountain Healthcare began a quality improvement program to address sepsis, its sepsis mortality rate was 20.2%, among the lowest in the nation. By 2007, all 15 of its hospitals had deployed this program. A breakthrough came in recent years, when a phlebotomist was added to the team and contributed new insights into
ALL THE MISPLACED INCENTIVES OF A HEALTHCARE SYSTEM that uses fee-for-service to reimburse providers continue. The diverse spread of lab industry business intelligence presented in this issue of THE DARK REPORT vividly demonstrates that there continues to be a “best” and a “worst” in provider motives and behaviors during the last days of fee-for-service payment.